Virbac (VIRP) shares rise 10% on Q1 growth in North America

Virbac (VIRP) reported a 10% increase in shares due to strong Q1 growth in North America, which helped offset foreign exchange impacts. This growth indicates positive demand for their products in the region, which is significant for future earnings potential. The company's focus on North America has been successful, despite challenges from currency fluctuations. Overall, this performance may positively influence investor sentiment and market positioning for Virbac.